Bladder cancer frequently announces itself through symptoms that patients dismiss as minor urinary issues, and that delay ...

This Press Release identifies that Dr. Kulkarni has participated in a medical advisory position for Theralase(R) in the ...

A trial tested an enhanced recovery after surgery (ERAS) protocol in patients who underwent ambulatory transurethral resection (TURBT) of bladder cancer.

Draft guidance from NICE recommends durvalumab before and after surgery for muscle-invasive bladder cancer following phase 3 trial survival data.

For many people, spotting blood in the urine is often the first warning sign of bladder cancer. But for those with color ...

AstraZeneca has received a positive recommendation from the National Institute for Health and Care Excellence for durvalumab, ...

Although bladder cancer ranks as the sixth most common cancer in the United States, with approximately 85,000 new cases diagnosed each year, it continues to receive limited awareness, advocacy, and ...

On Feb. 18, 2026, investors weighed ImmunityBio’s EU bladder cancer win against its long slide since IPO and fresh legal ...

A hearing on a motion by L’Oreal USA Inc. and other cosmetic companies challenging the claims by 15 plaintiffs that their bladder cancer was due to exposure to carcinogenic and endocrine-disrupting ...

Armando, a 71-year-old with an active lifestyle, was midway through a round of golf when a strange sensation crept into his abdomen after drinking water. It was just a fleeting moment; one he brushed ...

Bladder cancer signs and symptoms can vary from person to person. The most common symptom is blood in the urine, also called hematuria. While this can turn the urine into a red or rusty color, it may ...

Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company dedicated to the research and development of energy-activated small ...